On the morning of May 26, 2021, Zhang Ping, member of the Standing Committee of the National People's Congress, vice chairman of the Central Committee of the China Democratic League, and vice chairman of the China Federation of Literary and Art Circles, Zhang Shizhen, vice governor of the People's Government of Gansu Province, member of the Standing Committee of the Central Committee of the China Democratic League, and chairman of the Gansu Provincial Committee, led the research team to Fuzheng Pharmaceutical for research and guidance. Dai Chao, deputy secretary of the Dingxi Municipal Party Committee and mayor, Li Bin, member of the Standing Committee of the Municipal Party Committee and director of the United Front Work Department of the Municipal Party Committee, Xie Yunfeng, member of the Standing Committee of the Anding District Committee and director of the United Front Work Department of the District Committee, Bao Zhengxue, chairman of Fuzheng Pharmaceutical, Zhang Tao, secretary of the Party Committee, and Yu Wugao, general manager, accompanied the investigation.
Chairman Bao Zhengxue expressed a warm welcome to the research team and the company, and introduced the company's development in detail, and during the visit and research process, the research group had a cordial and in-depth conversation with the company's leaders. While listening to the explanations, the research team stopped to watch the exhibits and multimedia introductions, and conducted a comprehensive understanding of the development of our company in recent years from the aspects of standardized planting, deep processing, marketing, and new drug research and development of Chinese herbal medicines. In particular, the newly developed targeted anti-tumor drugs afatinib maleate, abiraterone acetate and acetaminophen tablets newly developed by Gansu Lanyao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Fuzheng Pharmaceutical, have been highly recognized and evaluated by the State Drug Administration through the consistency evaluation of the State Drug Administration.
After the investigation, the research team pointed out that Dingxi, as a major city in the traditional Chinese medicine industry, has a long history of planting Chinese medicinal materials, and gives full play to and makes good use of the advantages of the main production areas of medicinal materials, builds the Longyao Cultural Center into a base for popular science education and academic research exchanges, comprehensively promotes the implementation strategy of rural revitalization, and further promotes the high-quality development of the traditional Chinese medicine industry.